Physician profile
John A Palesty
NPI 1942237516
$9,037.16
in general payments reported to CMS, 2019-2025
10 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,371 · 2021: $164 · 2022: $87.83 · 2023: $16.88 · 2024: $115 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,468.17 | 2019-2024 | |
| Davol INC. | $163.93 | 2021 | |
| Hydrofera LLC | $154.06 | 2025 | Hydrofera Blue, Sorbact Other |
| Solventum Corporation | $116.46 | 2024-2025 | V.A.C.Ulta, Prevena, Promogran Prisma |
| Kci USA, INC. | $38.65 | 2022 | |
| Smith+Nephew, INC. | $29.28 | 2025 | Grafix Pl, Stravix |
| Amgen INC. | $18.27 | 2019 | |
| Lemaitre Vascular, INC. | $16.88 | 2023 | Artegraft Vascular Graft |
| Amarin Pharma, INC. | $15.91 | 2019 | |
| Lifenet Health | $15.55 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Palesty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.